BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38702281)

  • 41. Assessment of the value of MRI scan in addition to CT in the pre-operative staging of colorectal liver metastases.
    Wiggans MG; Shahtahmassebi G; Aroori S; Bowles MJ; Jackson SA; Stell DA
    J Gastrointest Cancer; 2014 Jun; 45(2):146-53. PubMed ID: 24408271
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Surgical resection and peri-operative chemotherapy for colorectal cancer liver metastases: A population-based study.
    Booth CM; Nanji S; Wei X; Biagi JJ; Krzyzanowska MK; Mackillop WJ
    Eur J Surg Oncol; 2016 Feb; 42(2):281-7. PubMed ID: 26558526
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interaction of margin status and tumour burden determines survival after resection of colorectal liver metastases: A retrospective cohort study.
    Mao R; Zhao JJ; Bi XY; Zhang YF; Li ZY; Zhou JG; Zhao H; Cai JQ
    Int J Surg; 2018 May; 53():371-377. PubMed ID: 29229309
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Diagnosis and treatment of colorectal liver metastases - workflow].
    Grundmann RT; Hermanek P; Merkel S; Germer CT; Grundmann RT; Hauss J; Henne-Bruns D; Herfarth K; Hermanek P; Hopt UT; Junginger T; Klar E; Klempnauer J; Knapp WH; Kraus M; Lang H; Link KH; Löhe F; Merkel S; Oldhafer KJ; Raab HR; Rau HG; Reinacher-Schick A; Ricke J; Roder J; Schäfer AO; Schlitt HJ; Schön MR; Stippel D; Tannapfel A; Tatsch K; Vogl TJ;
    Zentralbl Chir; 2008 Jun; 133(3):267-84. PubMed ID: 18563694
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association between imaging response and survival following neoadjuvant chemotherapy in patients with resectable colorectal liver metastases: A cohort study.
    Behrenbruch C; Prabhakaran S; Udayasiri D D; Michael M; Hollande F; Hayes I; Heriot AG; Knowles B; Thomson BN
    J Surg Oncol; 2021 Apr; 123(5):1263-1273. PubMed ID: 33524184
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Outcomes evaluation of laparoscopic radical coloproctectomy and hepatectomy for resectable colorectal cancer with liver metastases].
    Yao H; Xiu D; Fu W; Sun T; Jiang B; Ma C; Yuan C; Yuan J; Wang D
    Zhonghua Wai Ke Za Zhi; 2014 Dec; 52(12):919-23. PubMed ID: 25622583
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Post-chemotherapeutic CEA and CA19-9 are prognostic factors in patients with colorectal liver metastases treated with hepatic resection after oxaliplatin-based chemotherapy.
    Sakamoto Y; Miyamoto Y; Beppu T; Nitta H; Imai K; Hayashi H; Baba Y; Yoshida N; Chikamoto A; Baba H
    Anticancer Res; 2015 Apr; 35(4):2359-68. PubMed ID: 25862901
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?
    Adam R; Pascal G; Castaing D; Azoulay D; Delvart V; Paule B; Levi F; Bismuth H
    Ann Surg; 2004 Dec; 240(6):1052-61; discussion 1061-4. PubMed ID: 15570210
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of resection for primary colorectal cancer on outcomes in patients with synchronous colorectal liver metastases.
    Huh JW; Cho CK; Kim HR; Kim YJ
    J Gastrointest Surg; 2010 Aug; 14(8):1258-64. PubMed ID: 20544397
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical features and prognosis in hepatectomy for colorectal cancer with centrally located liver metastasis.
    Kuo IM; Huang SF; Chiang JM; Yeh CY; Chan KM; Chen JS; Yu MC
    World J Surg Oncol; 2015 Mar; 13():92. PubMed ID: 25889950
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical relevance of oncologic prognostic factors in the decision-making of pre-hepatectomy chemotherapy for colorectal cancer hepatic metastasis: the priority of hepatectomy.
    Chan KM; Wu TH; Wang YC; Lee CF; Wu TJ; Chou HS; Lee WC; Chiang JM; Chen JS
    World J Surg Oncol; 2018 Feb; 16(1):24. PubMed ID: 29415722
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases.
    Chun YS; Vauthey JN; Boonsirikamchai P; Maru DM; Kopetz S; Palavecino M; Curley SA; Abdalla EK; Kaur H; Charnsangavej C; Loyer EM
    JAMA; 2009 Dec; 302(21):2338-44. PubMed ID: 19952320
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Surgical Resection for Recurrence After Two-Stage Hepatectomy for Colorectal Liver Metastases Is Feasible, Is Safe, and Improves Survival.
    Lillemoe HA; Kawaguchi Y; Passot G; Karagkounis G; Simoneau E; You YN; Mehran RJ; Chun YS; Tzeng CD; Aloia TA; Vauthey JN
    J Gastrointest Surg; 2019 Jan; 23(1):84-92. PubMed ID: 30084064
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aggressive recurrences determine oncologic outcomes after resection of liver metastases from primary right colon cancer: Results of a case-control study.
    Zimmitti G; Panettieri E; Ardito F; Mele C; Maria V; Rosso E; Nuzzo G; Giuliante F
    Eur J Surg Oncol; 2021 Apr; 47(4):834-841. PubMed ID: 33032866
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chemotherapy for colorectal cancer prior to liver resection for colorectal cancer hepatic metastases does not adversely affect peri-operative outcomes.
    Sahajpal A; Vollmer CM; Dixon E; Chan EK; Wei A; Cattral MS; Taylor BR; Grant DR; Greig PD; Gallinger S
    J Surg Oncol; 2007 Jan; 95(1):22-7. PubMed ID: 17066435
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Liver resection for colorectal metastases: the third hepatectomy.
    Adam R; Pascal G; Azoulay D; Tanaka K; Castaing D; Bismuth H
    Ann Surg; 2003 Dec; 238(6):871-83; discussion 883-4. PubMed ID: 14631224
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pre-hepatectomy dynamic circulating tumor DNA to predict pathologic response to preoperative chemotherapy and post-hepatectomy recurrence in patients with colorectal liver metastases.
    Liu M; Bao Q; Zhao T; Huang L; Zhang D; Wang Y; Yan X; Wang H; Jin K; Liu W; Wang K; Xing B
    Hepatol Int; 2024 Jun; 18(3):1029-1039. PubMed ID: 38427145
    [TBL] [Abstract][Full Text] [Related]  

  • 58. RAS Mutation is Associated with Unsalvageable Recurrence Following Hepatectomy for Colorectal Cancer Liver Metastases.
    Okuno M; Goumard C; Kopetz S; Vega EA; Joechle K; Mizuno T; Omichi K; Tzeng CD; Chun YS; Vauthey JN; Conrad C
    Ann Surg Oncol; 2018 Aug; 25(8):2457-2466. PubMed ID: 29786130
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Resection of Concomitant Hepatic and Extrahepatic Metastases from Colorectal Cancer - A Worthwhile Operation?
    Diaconescu A; Alexandrescu S; Ionel Z; Zlate C; Grigorie R; Brasoveanu V; Hrehoret D; Ciurea S; Botea F; Tomescu D; Droc G; Croitoru A; Herlea V; Boros M; Grasu M; Dumitru R; Toma M; Ionescu M; Vasilescu C; Popescu I
    Chirurgia (Bucur); 2017; 112(6):673-682. PubMed ID: 29288609
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ferumoxide-enhanced magnetic resonance imaging techniques in pre-operative assessment for colorectal liver metastases.
    van Etten B; van der Sijp J; Kruyt R; Oudkerk M; van der Holt B; Wiggers T
    Eur J Surg Oncol; 2002 Sep; 28(6):645-51. PubMed ID: 12359202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.